XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Activities:      
Net loss $ (978) $ (128,071) $ (148,173)
Adjustments to reconcile Net loss to net cash provided by (used in) operating activities:      
Provision for credit loss 833 123 91
(Gain) loss on right of use assets 0 143 (289)
Gain on sale of property and equipment (72) (9) 0
Depreciation and amortization 30,482 27,062 21,668
Amortization-debt issuance costs 1,761 1,293 1,254
Amortization-investment discount (1,298) (2,579) (4,917)
Equity-based compensation 62,082 71,132 66,835
Non-cash lease expense 1,609 1,764 2,318
Loss on extinguishment of debt 0 3,020 0
Changes in operating assets and liabilities:      
Accounts receivable (100,106) (34,278) (26,950)
Prepaid expenses and other current assets (57,059) 7,887 (2,863)
Other assets (50) 60 (142)
Medical expenses payable 184,781 84,389 35,264
Accounts payable and accrued expenses 10,364 (1,460) (6,347)
Accrued compensation 9,082 5,819 6,574
Lease liabilities (1,504) (1,525) (3,510)
Net cash provided by (used in) operating activities 139,927 34,770 (59,187)
Investing Activities:      
Purchase of investments (65,633) (82,200) (379,058)
Sale of property and equipment 75 14 0
Maturities of investments 76,300 162,795 267,790
Sale of business 1,065 0 0
Acquisition of property and equipment, net (26,781) (41,418) (35,995)
Net cash provided by (used in) investing activities (14,974) 39,191 (147,263)
Financing Activities:      
Proceeds from long-term debt 0 380,000 0
Debt issuance costs (26) (8,792) 0
Repayment of long-term debt 0 (215,000) 0
Payment of employment taxes related to release of restricted stock 0 (350) 0
Proceeds from exercise of stock options 18,067 155 0
Contributions from noncontrolling interest holders 0 15 105
Net cash provided by financing activities 18,041 156,028 105
Net increase (decrease) in cash 142,994 229,989 (206,345)
Cash, cash equivalents and restricted cash at beginning of period 434,943 204,954 411,299
Cash, cash equivalents and restricted cash at end of period 577,937 434,943 204,954
Supplemental disclosure of cash flow information:      
Cash paid for interest 13,752 22,157 19,165
Supplemental non-cash investing and financing activities:      
Acquisition of property in accounts payable 97 70 59
Debt issuance costs in accounts payable 0 512 0
Reconciliation of cash, cash equivalents and restricted cash as shown in the statement of cash flows:      
Cash and cash equivalents 575,817 432,859 202,904
Restricted cash in other assets 2,120 2,084 2,050
Total $ 577,937 $ 434,943 $ 204,954